|
... DAY TRADER
.. March 7, 2007, 7:30am. No action.
March 6, 2007... 10:57am .. SELL VOL - last $29.15 . Performance not to expectations as macd contracting. ... 10:36am ... BUY Volt Information Systems (VOL) - last $28.88 . After off 2.57 points, VOT has finally received better macd numbers. Trade to $30.40 likely.
March 5, 2007 1:54pm ... COVER SHORT #2 on SDS - last $61.67 .... 1:28pm ... SHORT #2 on SDS - last $62.08 .... 12:55pm .... COVER SHORT on SDS - last $61.90 .... 12:34pm ... SHORT SDS - last $62.05 ..... 12:11pm ... SELL SDS - last $61.85 .... 10:30am ... BUY SDS - last $61.60 .
March 2, 2007... 1:31pm ... SELL TSAI - last $31.10 . Failed to attract up volume after false start.... 1:10pm ... BUY Transaction Systems (TSAI) - last $31.30 . After declining over 4 points, TSAI has been under accumulation with improving macd. BUT with test of $32.38..
.... From the 60-Day Summary list
... March 7, 2007
... 11:17am ... SELL SDS - last $61.03 . Take profit.
March 6, 2007 ...... 9:53am .. change exit price of NDEPG.X to $5.70. Take profit... 9:45am ... SELL NDE Ap '07 35 out (NDEPG.X) - last bid $7.00.
March 5, 2007... 10:40am ... COVER SHORT on HMIN - last $34.10 Originally suggested as SHORT at $37.45 on 03.02.07. Take profit.... 10:12am ... SELL SDS - last $61.40 . S&P index found support at 1390.
March 2, 2007... 12:34pm ... SELL Scottish Re Group (SCT) - last $4.46 . Suggest at average cost of $3.65 on 02.21.07. Take profit and allow the new group to pull the stock lower to acquire more common stock.... 9:37am .. SELL SDS - last $60.50 . Take profit.
___________________________
Net liquidation value of Stocksmirf Fantasy Hedge Fund (SFHF) portfolio for the period ending 02.28.07.........,........ $ 5,194,411.00
REALIZED GAINS LOSSES FOR THE MONTH OF OCTOBER '06 in the SFHF portfolio ........................ ......... $277,601.00
REALIZED GAINS LOSSES FOR THE MONTH OF NOVEMBER '06 in the SFHF portfolio. ............................... $338,049.00
REALIZED GAINS LOSSES FOR THE MONTH OF DECEMBER '06 in the SFHF portfolio ...... ......................... $371,020.00
REALIZED GAINS LOSSES FOR THE MONTH OF JANUARY '07 in the SFHF portfolio ..................................... $615,500.00
REALIZED GAINS LOSSES FOR THE MONTH OF FEBRUARY '07 in the SFHF portfolio .................... $1,092,241.00
REALIZED GAINS LOSSES FOR MONTH OF MARCH '07 to date in the SFHF portfolio ........................ $318,700.00
UNREALIZED GAINS (LOSSES) in the Stocksmirf Fantasy Hedge Fund portfolio. 
March 7, 2007, 4:00pm ......... $200,200.00
March 6, 2007, 4:00pm ........... $84,100.25
March 5, 2007, 4:00pm ........... $20,350.00
March 2, 2007, 4:00pm ............ $21,659.74
March 1, 2007, 4:00pm ........... $05,100.00
February 28, 2007, 4:00pm ..... $69,451.04
February 27, 2007, 4:00pm .... $225,225.00
__________________________________
Prior Dartline summaries ..... March 2, 2007, 7:30am ...  ...Considering yesterday's reaction in the morning, the S&P 500 index came close to losing 5 percent from the February highs hit the week before. Wall Street pundits claim a "floor of support" is due. Don't believe the spin and continue to converse cash. If you were following Dartline, most long positions would have been materially reduced. Indeed, if you're still in, attempt to liquidate into any rally. In the current environment long-term investing is out of fashion. .... What's next? Since the S&P 500 index is our :"post" as in posting the future direction of the broader stock market, what happens next requires a technical confirmation. For example (use archives): (1) December 11, 2006 said. "At 1409.84 as Friday's closing price for the S&P 500 index with a range of 1403.67 to 1414.09 should be the extent of upside resistance, while a decline below 1403 would suggests weaker values." In this directive a clear channel was established. (2) December 28, 2006 said: "The Standard & Poor's 500 index at 1426.84 remains our safety [valve]. .... Support is set at 1410 and represents an important Dartmarker to set your sights on." As suggested - if the S&P remained above 1410 you're a buyer with limited risk. Look at the SFHF portfolio gains to underscore this prediction. (3) January 17, 2007 said: "The resiliency of the S&P 500 index to advance despite contracting volume and lack of conviction in most sectors indicates that the underlying strength cannot be denied. At this point, one cannot deny the tape. For now, remain aggressive, but prudent ..." (4) February 5, 2007 said: "Don't panic. For the time being, 1450 is still upside resistance, while 1410 support. Within this range there are opportunities to participate ... without inflecting critical risk.' (5) February 20, 2007 said {scroll down in this column). "With the S&P index at 1455.55 the technical underpinnings to the market remain positive. .... Use 1435 as support to reduce any downside risk ..." (6) February 23, 2007, 10:73am said. "S&P 500 index below 1435 represents interim sell signal. Reduce exposure on long positions.". The rest was history. ... What's next? Yesterday, the S&P 500 closed at 1403.17 3.65. As stated on February 28, 2007, 7:30am, "Interim phase support is set at 1365, while 1325 represents primary support ..." Thus, we ave established our near-term floor. For now, remain balanced with most cash reserves on the sidelines. Allow the general market to point its direction with limited long positions.
March 1, 2007, 2:11pm ...  ... S&P 500 index found interim strength at 1400 and triggered buying interest. However, further weakness is likely and don't be fooled by the upside action. Sell long positions without "story" to conserve cash. ... 10:00 ... ... S&P 500 index support re-set at 1300. Key indicator at 1300 is needed to stabilize broader market. ..... 9:00am ...  S&P 500 index futures selling-off, suggesting renewed downside pressure and break below 1396. Reduce long positions further; need for capital preservation warranted. ... 7:30am ....  The S&P 500 index closed at 1,406.82 7.78 on the partial recovery of the Shanghai stock market and the welcome words of Fed Chairman Bernanke who said there was no single trigger to Tuesday's market slide and financial markets "seem to be working well." Yet, after how violent and quick the plunge of 416 points was on Tuesday, a rebound appeared a logical progression. Now the $64 question: How firm will this rebound be? Without a crystal ball, the answer belongs with the gods. For us lowly dart throwers, we must anticipate the future direction of the S&P and that event will be the key. Yesterday, the index declined to 1,396.65, therefore, a near-term support is determined. If the index holds above that number, nibble on the long side; keep your powder dry, and basically remain on the sidelines, except to "ambush" a special situation.
Prior Best Ideas ... March 2, 2007, 7:30. ... BUY #2 on BioCryst Pharmaceuticals Inc. (BCRX) at - last 9.88 . NCRX designs and develops novel drug that block key enzymes involved in cancer, cardiovascular diseases, etc .Originally focused as a "bird-flue" play, the company has a promising pipeline, which the 'crown jewel' is Fodosine, a oncology candidate as an inhibitor that controls abnormal multiplication of T-cells. Being the only such drug in development, NCRX recently started phase II study under a special FDA protocol assessment.- a significant factor since FDA can grant approval without phase III trials. The event triggers a $5 million milestone payment from partner Mundipharma. Fodosine has the potential of being a $1 billion plus drug. However, may not have the drug to market until '08 at the earliest. Therefore, the company's antiviral drug, Peramivir, in phase II trials remains the near term play. The U.S. government's Department of Health and Human Services awarded BCRX $102.6 million to develop Peramivir.for seasonal and life-threatening influenza. Fundamentals are adequate. With 23.3 million share float, 45% participation by institutions, management holding 23%, while 12% of outstanding short, BCRX is within appropriate standards for a takeover. Baker Brothers Advisors LLC holds a 6% stake in BCRX and may approach Gilead Sciences Inc. (GILD) for a linkup. Consider BCRX a "special situtaion, high speculation" BUY in a weak stock market. Add to position.
March 1, 2007... 3:00pm ... BUY put options in NDE April '07 strike $35.00 put (NDEPG.X) - last ask $3.70 . NDE makes a business in Alt-A mortages, which are between prime and sub-prime mortages. With lower profits,, contracting business and possible liquidity issues, NDE may have fundamental problems which will affect technicals. Buying the put options offers greater leverage, especially with the underlying stock tracking lower, possibly to the $25-$29 range... 11:36am .. BUY #3 on SDS - last $59.74 .... 10:45am ... BUY #2 on SDS - last $60.20 ... 9:32am ... SDS opened at $61.40. ... 9:15am .. BUY PT ULTRSHRT SP500 PS (SDS) - pre-market $59.65 . S&P 500 profile (ETF) on shorting underlying stocks.
February 28, 2007... 1:12pm ... BUY Staples Inc. (SPLS) - last $26.07 . At 16 times forward earnings and 23% return on equity SPLS is a value play with limited downside risk. EXIT POINT established at $29.50 mid-term... 12:11pm .. BUY #2 NVLS - last $32.00 . Add to long position.... 11:01am .. BUY Novellus Systems (NVLS) - last $32.44 Under accumulation ahead of earnings. At 17 times forward P/E, NVLS has excellent short term value into the $34-$36 range. 9:40am ... BUY SDS - last $60.20 .
February 27, 2007,.. 11:58am ... BUY PT Ultrashort SP500 PS (SDS) - last $57.84 . S&P 500 profile index (ETF) based on shorting the underlying stocks. With the S&P 500 index failed to support the 1435 level establish a technical sell signal. SDS will follow the decline to interim support at 1365.00.
......Note:
Changes will be instantly broadcast on our Message
Board. Log-in,
it's free. 
|